PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
8,50 US$
0,00%
(0,00) 1 Д
12. окт, 10:22:09 GMT-4 · USD
search
Сви симболи
| Симбол | Цена | Промена | % промене |
|---|
insights_autoГенеришу се најзначајнији увиди за PTKFY...
Трж. капитализација
33,00 бил.
Прос. количина
1,96 хиљ.
Количина
148,00
Највиша у 52 недеље
16,36 US$
Најнижа у 52 недеље
7,63 US$
Бета
0,09
Акцијски капитал
234,07 мил.
Бр. запослених
13 хиљ.
Трж. капитализација
33,00 бил.
Прос. количина
1,96 хиљ.
Количина
148,00
Највиша у 52 недеље
16,36 US$
Најнижа у 52 недеље
7,63 US$
Бета
0,09
Акцијски капитал
234,07 мил.
Бр. запослених
13 хиљ.
Вести
Из веб-извора и од партнера за вести
ad-hoc-news.de
·
пре 18 сати
Kalbe Farma launches IDR 500 billion buyback while Kiwoom targets Kalbe Farma stock
ad-hoc-news.de
·
пре 1 дана
Kalbe Farma launched an IDR 500 billion buyback of Kalbe Farma stock
Профил
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
PT Kalbe Farma Unsponsored Indonesia ADR – основни подаци